In April 2024, French active ingredient supplier Silab launched Metallomia™, a 100% natural bio-active derived from organic marshmallow roots (*Althaea officinalis*) engineered to combat metallo-ageing in menopausal skin. The water-soluble ingredient targets ferritinophagy—the cellular mechanism governing iron storage and release—to prevent intracellular free iron overload at a recommended inclusion rate of 1%.
Silab developed the ingredient following in-house research into cellular iron homeostasis in mature cohorts. Positioned for integration into anti-ageing treatments, dedicated menopausal ranges, and environmental defence care, the active aims to address physiological skin changes driven by hormonal shift.
The Science of Metallo-Ageing
Ferritin is the primary intracellular protein responsible for storing iron safely within skin cells. Under normal physiological conditions, a selective autophagy process known as ferritinophagy degrades ferritin to release iron when cellular processes require it. However, the systemic loss of oestrogen during menopause disrupts this cellular balance, leading to an abnormal accumulation of free iron within epidermal cells.
When skin laden with excess free iron is exposed to ultraviolet light, it triggers the Fenton reaction. This chemical process converts bio-available ferrous iron (Fe2+) into destructive hydroxyl radicals, creating intense localised oxidative stress. This accelerated degradation pathway, known as metallo-ageing, weakens skin barrier function, slows cell turnover, and reduces overall tissue density.
Metallomia™ is designed to interrupt this sequence by restoring normal ferritinophagy dynamics. By regulating the release of bio-available free iron, the active prevents intracellular iron accumulation, reduces oxidative damage, and helps preserve epidermal integrity under environmental stress.
Target Demographic and Market Competition
The launch lands Silab in the middle of a broader competitive shift across the active ingredients sector. Major suppliers including Givaudan, Lubrizol, and Sederma have all expanded their specialty portfolios to address hormone-driven skin changes, moving away from broad anti-ageing claims toward specific life-stage physiology.
Silab reported that *in vitro* and *in vivo* testing on menopausal cohorts confirmed that Metallomia™ significantly reduces intracellular free iron accumulation. Trial subjects showed diminished markers of oxidative stress alongside improvements in both skin density and visual radiance.
By anchoring the active specifically to cellular iron management, Silab is attempting to carve out a distinct biological positioning within the well-ageing category.
Formulation Specs and Regulatory Rollout
Silab's technical literature specifies that Metallomia™ is derived entirely from organic marshmallow roots (*Althaea officinalis*), fully soluble in water, and effective at a 1% concentration in finished formulas. Silab has not disclosed specific performance profiles across varying pH ranges, complex cosmetic bases, or surfactant systems.
The next phase for Metallomia™ will depend on commercial uptake and regulatory processing. Brand adoption across prestige and mass-market menopausal lines will test whether formulators view metallo-ageing as a compelling claim platform. Meanwhile, regulatory processing across key international markets—specifically REACH registration status in Europe and inclusion on China's Inventory of Existing Cosmetic Ingredients (IECIC)—will dictate how broadly global beauty conglomerates can deploy the active in international portfolios.